Bridgeway Capital Management, LLC Singular Genomics Systems, Inc. Transaction History

Bridgeway Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.33 - $0.58 $51,480 - $90,480	-156,000 Reduced 56.22%	121,500 $55,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.28 $41,418 - $67,968	53,100 Added 23.66%	277,500 $230,000
Q1 2023 May 15, 2023	SELL	$1.1 - $2.95 $3,410 - $9,145	-3,100 Reduced 1.36%	224,400 $271,000
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $392,392 - $584,276	215,600 Added 1811.76%	227,500 $457,000
Q3 2022 Nov 14, 2022	SELL	$2.5 - $4.73 $4,000 - $7,568	-1,600 Reduced 11.85%	11,900 $30,000
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $38,610 - $86,940	13,500 New	13,500 $52,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $948M
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.